| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |